跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,965 条关于
“Xeris Biopharma Holdings”
全部
2,965
临床试验
103
药物
458
机构
351
资讯
2,053
7个月前
Xeris Biopharma Files Patent Infringement Lawsuit to Protect Recorlev Against Generic Competition
去年
Xeris Biopharma Appoints Dr. Anh Nguyen as Chief Medical Officer to Lead Product Development Strategy
去年
Xeris Secures Additional Orange Book Patent Protection for Recorlev Through 2040
去年
FDA Approves Xeris Biopharma's Gvoke VialDx as First Ready-to-Dilute Liquid Glucagon for Gastrointestinal Diagnostics
去年
Matinas BioPharma's MAT2203 Shows Promise in Combating Severe Fungal Infections
去年
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM ... - USA Today
去年
Sareum's SDC-1801 Advances to Phase II Trials for Psoriasis Following Positive Phase I Results
去年
European Commission Approves Novo Holdings' $16.5B Catalent Acquisition
2年前
Bio-Path Holdings' BP1003 Demonstrates Therapeutic Potential in Diverse Cancers
去年
Novo Holdings Invests in SCHOTT Poonawalla to Strengthen Injectable Drug Packaging Capabilities in India
第 1 页,共 206 页
上一页
下一页